Financials Haleon plc

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Market Closed - London S.E. 11:35:01 2024-04-26 am EDT 5-day change 1st Jan Change
334.4 GBX +0.87% Intraday chart for Haleon plc +2.64% +3.96%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 30,229 29,703 30,538 - -
Enterprise Value (EV) 1 40,097 38,217 38,384 37,643 37,089
P/E ratio 28.5 x 28.5 x 20.7 x 18.1 x 16.9 x
Yield - 1.87% 1.88% 2.15% 2.39%
Capitalization / Revenue 2.78 x 2.63 x 2.67 x 2.56 x 2.45 x
EV / Revenue 3.69 x 3.38 x 3.35 x 3.15 x 2.97 x
EV / EBITDA 14.7 x 13.5 x 13.4 x 12.5 x 11.7 x
EV / FCF 22.8 x 20.5 x 26.2 x 22.1 x 20.4 x
FCF Yield 4.39% 4.88% 3.81% 4.53% 4.89%
Price to Book 1.85 x 1.79 x 1.79 x 1.69 x 1.59 x
Nbr of stocks (in thousands) 9,234,574 9,234,574 9,132,301 - -
Reference price 2 3.274 3.216 3.344 3.344 3.344
Announcement Date 3/2/23 2/29/24 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 10,858 11,302 11,447 11,931 12,473
EBITDA 1 2,730 2,831 2,866 3,019 3,167
EBIT 1 1,825 2,549 2,582 2,717 2,876
Operating Margin 16.81% 22.55% 22.56% 22.77% 23.05%
Earnings before Tax (EBT) 1 1,618 1,628 2,043 2,346 2,443
Net income 1 1,060 1,049 1,471 1,693 1,798
Net margin 9.76% 9.28% 12.85% 14.19% 14.42%
EPS 2 0.1150 0.1130 0.1616 0.1846 0.1975
Free Cash Flow 1 1,759 1,866 1,464 1,706 1,815
FCF margin 16.2% 16.51% 12.79% 14.3% 14.55%
FCF Conversion (EBITDA) 64.43% 65.91% 51.09% 56.53% 57.29%
FCF Conversion (Net income) 165.94% 177.88% 99.55% 100.78% 100.9%
Dividend per Share 2 - 0.0600 0.0630 0.0720 0.0800
Announcement Date 3/2/23 2/29/24 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1
Net sales 1 2,627 - 5,188 2,892 2,778 5,670 2,986 2,752 5,738 2,798 2,766 5,564 2,941 2,778 5,668 2,908 2,870 5,761 -
EBITDA - - - - - - - - 1,406 - - 1,425 - - - - - - -
EBIT 1 - - - 569 356 - 627 644 1,271 689 589 1,278 590 476 - 638 439 - -
Operating Margin - - - 19.67% 12.81% - 21% 23.4% 22.15% 24.62% 21.29% 22.97% 20.06% 17.13% - 21.94% 15.29% - -
Earnings before Tax (EBT) - - - - - - - - - - 172 - - - - - - - -
Net income 1 343 - - - - - - 298 - 365 -3 - 368.2 322.6 - 461 359.6 - -
Net margin 13.06% - - - - - - 10.83% - 13.05% -0.11% - 12.52% 11.61% - 15.85% 12.53% - -
EPS 2 - 0.0189 - 0.0400 - - - 0.0320 - 0.0390 - - 0.0404 0.0354 - 0.0505 0.0394 - -
Dividend per Share 2 - - - - - - - - 0.0180 - - 0.0420 - - 0.0220 - 0.0643 0.0470 -
Announcement Date 6/1/22 9/29/22 9/29/22 11/10/22 3/2/23 3/2/23 5/3/23 8/2/23 8/2/23 11/2/23 2/29/24 2/29/24 - - - - - - -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 9,868 8,514 7,846 7,105 6,551
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) 3.615 x 3.007 x 2.738 x 2.354 x 2.068 x
Free Cash Flow 1 1,759 1,866 1,464 1,706 1,815
ROE (net income / shareholders' equity) 4.97% 6.37% 9.76% 10% 10.3%
ROA (Net income/ Total Assets) 3.06% 3.05% 4.48% 4.77% 5.07%
Assets 1 34,633 34,435 32,797 35,477 35,484
Book Value Per Share 2 1.770 1.790 1.860 1.980 2.100
Cash Flow per Share 2 0.2200 0.2300 0.1600 0.2100 0.2300
Capex 1 304 234 338 342 368
Capex / Sales 2.8% 2.07% 2.95% 2.87% 2.95%
Announcement Date 3/2/23 2/29/24 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.344 GBP
Average target price
3.594 GBP
Spread / Average Target
+7.47%
Consensus
  1. Stock Market
  2. Equities
  3. HLN Stock
  4. Financials Haleon plc